Short-term KST
Previous Close | 17.58 |
Open | 17.45 |
Bid | 17.31 x 1100 |
Ask | 17.43 x 1200 |
Day's Range | 16.86 - 17.57 |
52 Week Range | 6.21 - 17.82 |
Volume | |
Avg. Volume | 31,322 |
Market Cap | 278.129M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Nuvectis Pharma, Inc. (NVCT) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Corsair Gaming, Nuvectis Pharma and WisdomTree have been highlighted in this Screen of The Week article.
Invest in breakout stocks such as Corsair Gaming (CRSR), Nuvectis Pharma (NVCT) & WisdomTree (WT) as of now for solid returns.
Nuvectis Pharma, Inc. (NVCT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
The average of price targets set by Wall Street analysts indicates a potential upside of 29.4% in Nuvectis Pharma, Inc. (NVCT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Key Insights Nuvectis Pharma's significant insider ownership suggests inherent interests in company's expansion The top...
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...
How far off is Nuvectis Pharma, Inc. ( NASDAQ:NVCT ) from its intrinsic value? Using the most recent financial data...
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
To get a sense of who is truly in control of Nuvectis Pharma, Inc. ( NASDAQ:NVCT ), it is important to understand the...
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...